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Abstract 
Major depression might originate from both environmental and genetic risk factors. The 
environmental chronic mild stress (CMS) model mimics some environmental factors 
contributing to human depression and induces anhedonia and helplessness. Mice 
heterozygous for the synaptic vesicle protein (SVP) vesicular glutamate transporter 1 
(VGLUT1) have been proposed as a genetic model of deficient glutamate function linked to 
depressive-like behaviour. Here, we aimed to identify, in these two experimental models, 
gene expression changes in the frontal cortex, common to stress and impaired glutamate 
function.  
Both VGLUT1+/- and CMS mice showed helpless and anhedonic-like behavior. Microarray 
studies in VGLUT1+/- mice revealed regulation of genes involved in apoptosis, 
neurogenesis, synaptic transmission, protein metabolic process or learning and memory. In 
addition, RT-PCR studies confirmed gene expression changes in several glutamate, GABA, 
dopamine and serotonin neurotransmitter receptors.  On the other hand, CMS affected the 
regulation of 147 transcripts, some of them involved in response to stress and 
oxidoreductase activity. Interestingly, 52 genes were similarly regulated in both models. 
Specifically, a dowregulation in genes that promote cell proliferation  (Anapc7), cell growth 
(CsnK1g1), cell survival (Hdac3), inhibition of apoptosis (Dido1) was observed. Genes 
linked to cytoskeleton (Hspg2, Invs), psychiatric disorders (Grin1, MapK12) or an 
antioxidant enzyme (Gpx2) were also downregulated. Moreover, genes that inhibit the MAPK 
pathways (Dusp14), stimulate oxidative metabolism (Eif4a2) and enhance glutamate 
transmission (Rab8b) were upregulated. 
We suggest that these genes could form part of the altered “molecular context” underlying 
depressive-like behaviour in animal models. The clinical relevance of these findings is 
discussed.  
 
 
 1. Introduction  
Increasing evidence suggests that major depression might originate from both 
environmental and genetic risk factors.  This observation early prompted the need to 
better refine and develop mouse-specific models for analysing depression. For 
instance, the chronic mild stress (CMS) model of depression was developed (Willner, 
2005) in an attempt to mimic some of the environmental factors contributing to the 
induction of depressive disorders in humans (Kessler, 1997; Kendler et al., 1999; 
2001; Monroe et al., 2006).  
CMS reproduces core clinical symptoms such as long-lasting anhedonia and 
helplessness (Elizalde et al., 2008). In addition, CMS induces neuroadaptive 
changes that could be addressing clinical findings with depressed patients (Gould et 
al., 2007; Sanacora et al., 2004; Rajkowska., 2000; Lucassen et al., 2006; Frodl et 
al., 2008).  
 
Recent clinical (Uezato et al., 2009) and preclinical studies (Tordera et al., 2007; 
García-García et al., 2009) have linked decreased levels of the synaptic vesicle 
protein (SVP) vesicular glutamate transporter 1 (VGLUT1) to depressive like 
behaviour. Specifically, decreased VGLUT1 levels in the frontal cortex of depressed 
subjects have been reported (Uezato et al., 2009) in post-mortem studies. In 
addition, recent studies with the VGLUT1 heterozygous mice (VGLUT1+/-) suggest 
that decreased VGLUT1 levels affects glutamate transmission (Balschun et al., 2009) 
and induces depressive-like behavior comorbid with anxiety and impaired recognition 
memory (Tordera et al., 2007).  Moreover, VGLUT1+/- mice show decreased cortical 
and hippocampal levels in GABA as well as an increased vulnerability to depressive-
like behaviour after chronic stress (García-García et al., 2009).   
 Here, we aimed to study, using microarray technology, how decreased VGLUT1 
levels (VGLUT1+/- mice) or an environmental model (chronic mild stress) affect 
behaviour and gene expression in the frontal cortex.  
Firstly, anhedonic and helpless behaviour in both VGLUT1+/- and CMS models was 
comparatively studied. Secondly, we evaluated differences in gene expression in 
VGLUT1+/- mice compared to WT. From all the significant genes, we selected some 
candidates to validate by RT-PCR considering their relationship with different 
neurotransmitter systems and the coincidence with another genetic animal model of 
depression, the CB1 KO mice (Aso et al., 2010, Special Issue). Differences in gene 
expression in the CMS model were also evaluated. Subsequently, gene expression 
changes common to the VGLUT1+/- and CMS models were selected and their 
possible involvement in depressive-like behaviour was discussed.  
  
 2. Experimental procedures  
 
2.1 Animals   
Heterozygous VGLUT1 male mice (VGLUT1+/-) C57BL⁄6N were bred from 
heterozygous fathers (Dr S. Wojcik, Gottingen, Germany) and WT mothers (Harlan, 
France). The VGLUT1-/- knock-out allele was generated by truncation of the coding 
region of the VGLUT1 gene between the start codon and a BglII site in the fifth 
coding exon through homologous recombination in embryonic stem cells (129/ola 
background) (Wojcik et al., 2004). These mice show a progressive neuropathological 
phenotype and increased lethality rate at 2–3 weeks after birth. Mice were weaned 
and genotyped at the age of 3 weeks. VGLUT1+/- heterozygous mice exhibited no 
apparent phenotypic abnormalities during development and adulthood. 
Heterozygous VGLUT1 and WT male mice (C57BL/6) (8-10 weeks of age) were 
housed in individual cages and allowed for 2 weeks to habituate before beginning 
experimentation. Food and water were available ad libitum for the duration of the 
experiments unless otherwise specified. Animals were maintained in a temperature 
(21 ± 1 ºC) and humidity-controlled room (55 ± 2 %) on a 12 h light-dark cycle (lights 
on at 08:00 h). 
Experimental procedures and animal husbandry were conducted according to the 
principles of laboratory animal care as detailed in the European Communities Council 
Directive (2003/65/EC), Spanish legislation (Real decreto 1201/2005) and approved 
by the Ethical Committee of University of Navarra.  
 
 
 2.2 Experimental design 
Both WT and VGLUT1+/- mice were divided into control and CMS groups 
(n=15mice/group, four groups, n=60 in total). Chronic mild stress (CMS) procedure 
was applied for six weeks (Elizalde et al., 2008). Anhedonic-like behavior was 
evaluated by weekly monitoring of sucrose intake in both control and CMS mice 
during the 6 weeks of the stress procedure. Over the last week of CMS, a battery of 
behavioural tests including motor activity, novel object recognition, test for anxiety 
(elevated plus maze) and depression (forced swimming test) were performed. The 
behavioural phenotype of these groups have been previously shown (García-García 
et al., 2009). Tests were performed from 9:00-1:00 p.m.  Animals were sacrificed 76 
h after the last test (forced swimming test) and 24 h after the last stress procedure. 
Mice were killed by cervical dislocation, brains were rapidly removed and the 
prefrontal cortex (around 15 mg) was rapidly dissected according to standard 
procedures and frozen in dry ice. Samples were stored at -80°C until RNA was 
isolated.  
 
2.3 Chronic mild stress procedure 
The following unpredictable mild stressors (2-3 in any 24 h period) were randomly 
applied for 6 weeks (Elizalde et al., 2008): stroboscopic illumination (8h), intermittent 
bell (10 db, 1s/10s) or white noise (4 h), rat odour (8h), cage tilt 45º (8 h), soiled 
bedding (6 h), paired housing (2h) overnight illumination, removal of nesting material 
(12 h) and confinement (1 h). Once a week, anhedonic-like behaviour was evaluated 
by weekly monitoring of sucrose intake (Elizalde et al., 2008). During the 15 h of 
duration of the sucrose intake test (from 6 p.m to 9 a.m.) no stressors were applied.   
  
 
2.4 Sucrose intake test  
Anhedonic like behaviour was evaluated by weekly monitoring of sucrose intake 
(Elizalde et al., 2008). Mice were first trained to drink a sucrose solution by exposing 
them to two standard drinking bottles, one containing 2.5 % sucrose and the other 
tap water, for every other night during one week. After this preliminary phase, mice 
were food deprived and exposed to the sucrose solution and water from 6:00 p.m. 
until 09:00 h in the morning, once a week during 6 weeks. The intake baseline for the 
sucrose solution was established, which corresponded to the average of three 
consecutive measurements.  
WT and VGLUT1+/- mice were subdivided into two groups (CMS and non-stressed 
controls) matched for sucrose consumption and body weight. Mice were weekly 
given a 15-h exposure to the sucrose solution and tap water as described above and 
during this test no stressors were applied. The position of the 2 bottles (right/left) was 
varied randomly from trial to trial. Body weight measurements were taken weekly and 
relative sucrose intake was calculated as absolute intake (g) per body weight.  
 
2.5 Forced swimming test 
Mice were individually placed into glass cylinders (height 24 cm, diameter 13 cm) 
containing water (14 cm, 22–23°C). Immobility, indicative of helpless behaviour, was 
recorded during the last 4 min of the 6 min testing period and is considered a 
measure of helpless behaviour.  
 
 2.6 RNA extraction 
Isolation of total RNA was carried out according to manufacturer’s instructions 
(NucleoSpin RNA II kit, Macherey-Nagel). Total RNA was isolated separately from 
each individal cortex. The frozen prefrontal cortex samples were lysed and dounze-
homogenized in the presence of a highly denaturing ß-mercaptoethanol-containing 
buffer, which immediately inactivates RNases. Ethanol was added to provide 
appropriate binding conditions, and the sample was then applied to an RNeasy Mini 
spin column, where the total RNA binded to the membrane and contaminants were 
washed away. RNA was then eluted in 30–60 μL RNase-free water. The eluates 
were stored at –80°C. 
 
2.7 Microarray hybridization 
 
RNA quality control was checked with the Agilent Bioanalyzer (Agilent Technologies 
Inc, Santa Clara, CA, USA) and the RNA concentration was evaluated by using a 
NanoDrop™ Spectrophotometer (Thermo Fisher Scientific, Wilmington, DE, USA). 
Microarray hybridizations were outsourced to ServiceXS B.V. (BZ Leiden, The 
Netherlands). Nine animals out of 15 in each group (control and CMS, WT and 
VGLUT1+/- mice) were used for large-scale gene expression analysis. Selection of 
the animals was based on the RNA quality from the frontal cortex extracts. RNA from 
groups of three animals was pooled to reduce noise and individual variability, giving 
three samples per group, which were treated as such for statistical analysis. The 
Illumina  TotalPrep™ RNA Amplification Kit®  (Ambion Inc, Austin, TX, USA) was used 
to synthesize biotine labeled cRNA. Then, 750 ng of biotin labeled cRNA were 
hybridized onto the MouseRef-8 v2.0 Expression BeadChips (Illumina Inc., San 
Diedo, CA, USA) accordingly to manufacturer’s instructions. The used multi-sample 
array format allows to assay approximately 25,600 transcripts and to profile eight 
samples simultaneously on a single MouseRef-8 v2.0 Expression BeadChip.  
 
2.8 Validation of the differentially expressed genes by RT-PCR  
TaqMan Low Density Arrays (TLDA) microfluidic card technology from Applied 
Biosystems (Foster City, CA, USA) was used to validate the differential expression of 
selected genes (Table 1) in 6 independent samples per group. Each reaction well 
contained all reagents specific for a given assay. For each tissue sample, 100 ng 
reverse-transcribed RNA were diluted to 50 μL with sterile water, combined with an 
equal volume of TaqMan Universal PCR Master Mix (2×; Applied Biosystems, Foster 
City, CA, USA), mixed by inversion, and spun briefly in an Eppendorf® 5415C 
microcentrifuge (Brinkmann Instruments, Westbury, NY, USA). After TLDAs were 
brought to room temperature, 100 μL master mix were loaded into each port 
connected to reaction wells. TLDAs were placed in Sorvall®/Heraeus® Custom 
Buckets (Applied Biosystems, Foster City, CA, USA) and centrifuged in a Sorvall 
Legend™ centrifuge (Kendro Scientific, Asheville, NC, USA) for 1 min at 331×g 
followed closely by a second 1-min centrifugation at 331 g. Cards with excess 
sample in the fill reservoir were spun for an additional 1 min. Immediately following 
centrifugation, the cards were sealed with a TaqMan LDA Stylus Staker (Applied 
Biosystems, Foster City, CA, USA), and the loading ports excised. The final volume 
in each well after centrifugation was <1.5 μL; thus, the final reverse-transcribed RNA 
concentration was approximately 1.5 ng/reaction. Quantitative RT-PCR amplifications 
were run on an ABI Prism® 7900HT Sequence Detection System (Applied 
Biosystems, Foster City, CA, USA) with a TaqMan LDA cycling block and an 
automation accessory upgrade. Thermal cycling conditions were 2 min at 50°C, 10 
min at 95°C, followed by 40 cycles of denaturation at 95°C for 15 s and annealing 
and extension at 60°C for 1 min. Each test sample was processed in duplicate on 
individual TLDA cards, thus allowing four samples to be processed on each card.  
 
2.9 Analysis of quantitative RT-PCR Data 
RT-PCR TaqMan instrumentation monitors gene-specific products with fluorescent 
dye chemistry. A cycle threshold (CT) for each reaction is the number of cycles at 
which the reaction crosses a selected threshold. The threshold is defined as a 
straight line drawn above noise/baseline and positioned within the linear region of the 
semi-log amplification plot. The fewer cycles required to reach threshold fluorescence 
intensity, the lower the CT value and the greater the initial amount of input target. 
Results for each target on TLDAs were quantified concurrently using the same 
baseline and threshold for a target gene in order to limit interplate errors in the 
analysis. 
Samples were analyzed by the double delta CT (ΔΔCT) method. Delta CT (ΔCT) 
values represent normalized target genes levels with respect the internal control. 
Normalization was based on a single reference gene (GAPDH). Delta CT (ΔΔCT) 
values were calculated as the ΔCT of each test sample (stressed wild-type or non-
stressed/stressed CB1 knockout mice) minus the mean ΔCT of the calibrator samples 
(non-stressed wild-type) for each target gene. The fold change was calculated using 
the equation 2(−ΔΔCT). 
  
2.10 Data normalization and analysis 
 
Behavioural studies. Immobility in the forced swimming test was analyzed using 
Student t-test analysis.  For the sucrose intake test one way ANOVA repeated 
measures followed by Student t-test for individual weeks was applied. 
Gene expression studies. Data normalization and gene expression analysis was 
carried out with the R/Bioconductor package beadarray (Dunning et al., 2007). The 
data normalization was performed by using the quantile normalization algorithm 
(Bolstad et al., 2003). The statistical analysis were based on the Propagating 
Uncertainty in Microarray Analysis (PUMA) method that allows to identify differentially 
expressed genes by combining biological replicates and to perform a principal 
component analysis (PCA) (Rattray et al, 2006). The filtering criterion used to define 
statistically significant differentially expressed genes was the minimum Pplr (MinPplr) 
lower than 0.001.  
Functional enrichment analysis of Gene Ontology (GO) categories 
(http://www.geneontology.org/) and KEGG pathways 
(http://www.genome.ad.jp/kegg/) was carried out using standard hypergeometric test 
(Huang et al, 2009). To identify biologically relevant clusters of interrelated genes a 
stringency criterion of p<0.01 were adopted in DAVID software (Huang et al, 2009).  
The functional interpretation and biological knowledge extraction was complemented 
through the use of Ingenuity Pathway Analysis (Ingenuity Systems, 
www.ingenuity.com), which database includes manually curated and fully traceable 
data derived from literature sources. Additionally, the lists of differentially expressed 
genes were browsed to find genes encoding neurotransmitter metabolizing enzymes, 
neurotransmitter receptors or receptor subunits, neurotrophic factors and others 
genes related to nervous system. 
 
 
  
 
 
 
  
3. Results 
3.1. Forced swimming and sucrose intake tests 
Mice body weight was not affected neither by CMS or genotype. CMS mice 
decreased sucrose intake (solution (g)/body weight) from the fourth week of CMS 
until the end of this procedure (Fig. 1A). VGLUT1+/- mice decreased also sucrose 
intake measured as the average of sucrose intake on three consecutive weeks (Fig. 
1C).   
In the forced swimming test (FST), increased immobility times were observed in CMS 
exposed mice (Fig. 1B). On the other hand, VGLUT1+/- heterozygous mice showed a 
significant increase in the immobility time in the FST compared to their WT littermates 
(Fig. 1D).   
 
3.2 Patterns of altered gene expression in VGLUT1+/- mice compared to WT 
We considered statistical significance levels of MinPplr<0.001 when comparing 
patterns of gene expression on microarray among the different groups. In addition, 
significant levels of MinPplr<0.005 were also considered when differences in gene 
expression levels were higher than 1.4 or lower than 0.7 times of WT control levels. 
The levels of 1046 gene transcripts were significantly affected by genotype in the 
prefrontal cortex at basal conditions being 583 dowregulated and 463 upregulated 
(see clustering analysis results in supplemental material, figure 1s).  
Following the The DAVID 2008 Functional Annotation Tool was used to identify 
enriched biological pathways in the lists of differentially expressed genes obtained 
according to KEGG pathways and GO categories. After this functional analysis a set 
of enriched KEGG pathways including apoptosis, neurogenesis, synaptic 
transmission, protein metabolic process or learning and memory were detected 
(summarized in Table 2).  
From all the significant genes, we selected some candidates to validate considering 
their relationship with different neurotransmitter systems and the coincidence with the 
results obtained by analyzing differential gene pattern in another animal model of 
depression, the CB1 KO mice (Aso et al., 2009). In total, the gene expression of 20 
transcripts was evaluated by quantitative RT-PCR (Table1). Among them, RT-PCR 
confirmed the differential expression of several genes involved in GABA and 
glutamate transmission, including a dowregulation of VGLUT1, ionotropic kainate 
glutamate receptor 5 (Grik5)  and an upregulation of GABA-A receptor subunits 
(Gabrg2 and Gabra3), GABA-B receptor subtype 1 (Gabbr1), glycine receptor beta 
subunit (Glrb), member of the Ras oncogene family 8 (Rab8b) and member A of the 
ras homolog gene family (Rhoa). In addition, a dowregulation of the dopamine 
receptor 1a (Drd1a) and an upregulation of the 5-hydroxytryptamine receptor 1A 
(Htr1a) and adenilate cyclase 8 (Adyc8) were also confirmed (Table 1).   
 
3.3 Patterns of altered gene expressions common to the chronic mild stress 
and VGLUT1+/- model 
Similarly, 147 transcripts showed significantly altered expression levels after 
exposure to CMS; 94 were downregulated and 41 were upregulated. (See clustering 
analysis results  in supplemental material, figure 2s).  CMS affected the regulation of 
147 transcripts, some of them involved in response to stress and oxidoreductase 
activity. We identified 52 genes similarly regulated by both the CMS and the 
VGLUT1+/- models being 37 downregulated and 15 upregulated. Among them, 
genes playing an important role on cell proliferation and survival, apoptosis, oxidative 
metabolism, glutamate transmission or cytoskeleton was included (Table 3, and see 
hierarchical clustering image in Figure 2). Specifically, a dowregulation in genes that 
promote cell proliferation  (Anapc7; anaphase promoting complex subunit 7), cell 
growth (CsnK1g1; casein kinase 1 gamma 1), cell survival (Hdac3; histone 
deacetylase 3), inhibition of apoptosis (Dido1; death induced-obliterator 1) was 
observed. Other genes linked to cytoskeleton (Hspg2; perlecan, Invs; inversin), 
psychiatric disorders (Grin1; glutamate receptor, ionotropic, MapK12;  mitogen-
activated protein kinase 12)  or an antioxidant enzyme (Gpx2; glutathione peroxidase 
2) were also downregulated. In addition, an upregulation of genes that inhibit the 
MAPK pathways (Dusp14; dual specificity phosphatase 14), stimulate oxidative 
metabolism (Eif4a2; eukaryotic translation initiation factor 4A2) and enhance 
glutamate transmission (Rab8b; member RAS oncogene family 8) was detected. On 
the other hand, genes supposed to be neuroprotective such as an inhibitor of 
apoptosis (Pip5k1a;  phosphatidylinositol-4-phosphate 5-kinase, type 1 alpha),  an 
stimulator of cell differentiation (Nedd9; neural precursor cell expressed 
developmentally down-regulated gene 9) as well as genes linked to antioxidant 
activity (Prnp; prion protein) or cytoskeleton (Catna1; catenin alpha 1) were also 
upregulated.  
 4. Discussion  
Here, we firstly show that in agreement with previous studies carried out in our 
laboratory (García-García et al., 2009; Elizalde et al., 2008) both the genetic 
(VGLUT1+/- mice) and the environmental (chronic mild stress) model of depression 
showed helpless and anhedonic-like behavior.  
The vesicular glutamate transporter 1 (VGLUT1) is the major isoform in cortical and 
hippocampal regions (Takamori et al., 2000; Fremeau et al., 2001), where it plays a 
key role in the vesicular uptake and synaptic transmission of glutamate (Wojcik et al., 
2004: Fremeau et al., 2004; Balschun et al., 2009) in telencephalic areas. Thus, the 
anhedonic and helpless behaviour shown by these mice could be linked to 
decreased glutamate transmission in those areas in which VGLUT1 is the major 
isoform.  In keeping with this, recent post mortem studies showing decreased cortical 
VGLUT1 in depressed subjects (Uezato et al., 2009) together with clinical findings of 
an excitatory inhibitory imbalance in the cortex of depressed patients (Sanacora et 
al., 2004; Bhagwagar et al., 2007) suggest that decreased VGLUT1 levels might 
have functional and clinical implications.  
Microarray studies in VGLUT1+/- mice revealed regulation of genes involved in 
apoptosis, neurogenesis, synaptic transmission, protein metabolic process or 
learning and memory. Importantly, given that glutamate transmission is reduced in 
both VGLUT1+/- (Balschun et al., 2009) and VGLUT2+/- mice (Moechars et al., 
2006) and that both complementary isoforms show identical pharmacological 
properties (Takamori et al., 2001) it would be interesting to identify which of these 
differentially expressed genes are common in both genetic models. These studies 
would add relevant information like which gene changes are directly linked to 
impaired glutamate transmission and which could be more related to developmental 
in a particular brain area.   
 We selected some candidates to validate by RT-PCR considering their relationship 
with different neurotransmitter systems and the coincidence with the results obtained 
by analyzing differential gene pattern in another animal model of depression, the CB1 
KO mice (Aso et al., In this Issue). Changes in several glutamate, GABA, dopamine 
and serotonin neurotransmitter receptors were confirmed. Interestingly, VGLUT1+/- 
ampal levels of GABA without 
adaptations with
mice showed an upregulation of GABA-A receptor subunits (Gabrg2 and Gabra3), 
GABA-B receptor subtype 1 (Gabbr1), glycine receptor beta subunit (Glrb) and a 
downregulation of the ionotropic kainate glutamate receptor 5 (Grik5). Some of these 
changes might have a clinical relevance for different psychiatric disorders. For 
instance, associations between a polymorphism in GRIK5 receptor subunit (Gratacos 
et al., 2009) and an upregulation of the Gabra3 (Massat et al., 2002) to bipolar 
disorder have been described.  
We suggest that the upregulation of the different GABA subunits and receptors could 
be a compensatory effect for decreased GABA levels in the synaptic cleft. Indeed, 
previous studies in our laboratory show that VGLUT1 heterozygous mice exhibit 
normal levels of glutamate but low cortical and hippoc
alterations of the GAD65 synthesizing enzyme (García-García et al., 2009). 
Moreover, these mice show a downregulation of the excitatory aminoacid transpoter 
1 (EAAT1) (García-García et al., 2009). It has been suggested that a downregulation 
of EAAT1 could limit the glial glutamate uptake from the synaptic cleft and limit the 
synthesis of GABA in the GABAergic neuron (Mathews and Diamond, 2003).  
Nowadays, there is growing evidence confirming the implication of the GABAergic 
dysfunction (Krystal et al., 2002; Brambilla et al., 2003; Tunnicliff and Malatynska., 
2003). Clinical studies have shown that depressed patients have reduced GABA 
levels in cortex demonstrated by proton magnetic resonance spectroscopy (MRS) 
duces 
(Sanacora et al., 1999, 2004), plasma (Tunnicliff and Malatynska., 2003) and 
cerebrospinal fluid. Moreover, preclinical studies show decreased GABA levels in 
animal models of depression (Brambilla et al., 2003; Gronli et al., 2007; Sanacora et 
al., 2007; Garcia-Garcia et al., 2009).  
On the other hand, the upregulation of both Rhoa and Rab8b could be also a 
compensatory effect for a decreased glutamate release in the VGLUT1 dependent 
glutamatergic terminals. Both proteins are involved in the glutamate synaptic streght 
and in the release of AMPA receptors to the dendritic spines (Gerges et al., 2004). 
Further studies should investigate whether AMPA transmission is affected in these 
mice. Taken together, the RT-PCR studies further support the idea of an altered 
balance between the excitatory (glutamate) and inhibitory (GABA) transmission in 
these mice.   
Among the rest of neurotransmitter receptors, a dowregulation of the dopamine 
receptor 1a (Drd1a) agree with the CB1 KO model (Aso et al., 2010, in this special 
issue).    
 
The chronic mild stress model has been extensively studied at the behavioural 
(Strekalova et al., 2004;2006) molecular (Airan et al., 2007; Gronli et al., 2007; 
Banasr et al., 2008; García-García et al., 2009) or cellular (Warner-Schmidt and 
Duman 2006; Jayatissa et al., 2008) levels. In addition to core symptoms of 
depression, such as long-lasting anhedonia (Elizalde et al., 2008), CMS in
neuroadaptive changes that could be addressing clinical findings with depressed 
patients (Gould et al., 2007; Sanacora et al., 2004; Rajkowska., 2000; Lucassen et 
al., 2006; Frodl et al., 2008). CMS affected the regulation of 147 transcripts, some of 
them involved in response to stress and oxidoreductase activity.  Here, we aimed to 
identify in these two experimental models (CMS and VGLUT1+/- mice), gene 
expression changes common to stress and impaired glutamate function.   
Specifically, a dowregulation in genes that promote cell proliferation (Anapc7) 
(Gieffers et al., 2001), cell growth (CsnK1g1) (Kusuda et al., 2000), cell survival 
ese changes agree different hypothesis that link major depression to 
. Yet, the functional relevance of these changes for major depression would 
e further supported by gene expression studies on other genetic models. 
(Hdac3) (Xia et al., 2007), inhibition of apoptosis (Dido1) (Fütterer et al., 2005) was 
observed. Genes linked to cytoskeleton (Hspg2, Invs) (Farach-Carson et al., 2008; 
Nürnberger et al., 2004), psychiatric disorders (Grin1, MapK12) (Georgi et al., 2007; 
Qi et al., 2006) or an antioxidant enzyme (Gpx2) (Ranjekar et al., 2003) were also 
downregulated. Moreover, genes that inhibit the MAPK pathways (Dusp14), (Kingler 
et al., 2008) stimulate oxidative metabolism (Eif4a2) (Cheyssac et al., 2008) and 
enhance glutamate transmission (Rab8b) (Gerges et al., 2004) were upregulated. 
Interestingly th
either structural changes such as an increased neuronal death, neurite atrophia or 
molecular changes that lead to a failure in synaptic function and plasticity (Duman et 
al., 2006)
b
On the other hand, perhaps as compensatory mechanims, genes supposed to be 
neuroprotective such as an inhibitor of apoptosis (Pip5k1a; phosphatidylinositol-
4phosphate 5-kinase, type 1 alpha),  (Bassi et al., 2008) an stimulator of cell 
differentiation (Nedd9; neural precursor cell expressed developmentally down-
regulated gene 9) (Sasaki et al., 2005) as well as genes linked to antioxidant activity 
(Prnp; prion protein) (Rachidi et al., 2003) or cytoskeleton (Catna1; catenin alpha 1) 
(Park et al., 2002) were upregulated.  
Summing up, we have identified here genes similarly regulated by both 
environmental (CMS) and genetic model (VGLUT1+/- heterozygous mice) that could 
form part of the altered “molecular context” underlying depressive-like behaviour in 
these models and might provide new insights into the molecular basis of clinical 
depression.  
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